Casdin Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,365,000
| Closed | -$13.9M | – | 45 |
|
|
2020
Q1 | $13.9M | Hold |
3,365,000
| – | – | 1.47% | 21 |
|
|
2019
Q4 | $16.2M | Hold |
3,365,000
| – | – | 1.49% | 22 |
|
|
2019
Q3 | $20.4M | Hold |
3,365,000
| – | – | 2.11% | 16 |
|
|
2019
Q2 | $21.8M | Hold |
3,365,000
| – | – | 2.04% | 17 |
|
|
2019
Q1 | $23.9M | Sell |
3,365,000
-450,000
| -12% | -$3.19M | 2.62% | 14 |
|
|
2018
Q4 | $18.5M | Buy |
3,815,000
+315,000
| +9% | +$1.53M | 3.17% | 13 |
|
|
2018
Q3 | $25.7M | Buy |
3,500,000
+100,000
| +3% | +$735K | 3.13% | 15 |
|
|
2018
Q2 | $21.7M | Sell |
3,400,000
-450,000
| -12% | -$2.87M | 3.03% | 15 |
|
|
2018
Q1 | $20.9M | Buy |
3,850,000
+1,120,000
| +41% | +$6.09M | 3.68% | 15 |
|
|
2017
Q4 | $11.4M | Buy |
2,730,000
+1,230,000
| +82% | +$5.13M | 2.77% | 17 |
|
|
2017
Q3 | $14.4M | Buy |
1,500,000
+815,000
| +119% | +$7.85M | 4.08% | 13 |
|
|
2017
Q2 | $8.1M | Buy |
685,000
+285,000
| +71% | +$3.37M | 3% | 12 |
|
|
2017
Q1 | $5.13M | Sell |
400,000
-110,000
| -22% | -$1.41M | 3.03% | 10 |
|
|
2016
Q4 | $6.24M | Sell |
510,000
-115,000
| -18% | -$1.41M | 5.16% | 8 |
|
|
2016
Q3 | $7.38M | Buy |
625,000
+210,000
| +51% | +$2.48M | 5.97% | 7 |
|
|
2016
Q2 | $3.61M | Buy |
+415,000
| New | +$3.61M | 3.59% | 12 |
|
|
2016
Q1 | – | Sell |
-310,000
| Closed | -$2.41M | – | 32 |
|
|
2015
Q4 | $2.41M | Buy |
+310,000
| New | +$2.41M | 2.13% | 16 |
|